accountwhich has outperformed its average competitor by 2.5 percentage points annually since its 2005 launch. Helm recommends Abbott Laboratories (ABT, Fortune 500), now yielding 3.1%. The $30 billion pharmaceutical giant, known for its rheumatoid arthritis...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Go the distance - Dividends for the long run
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account